<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00367731</url>
  </required_header>
  <id_info>
    <org_study_id>RVH_CER_003</org_study_id>
    <nct_id>NCT00367731</nct_id>
  </id_info>
  <brief_title>NOW Thai HAART Study</brief_title>
  <official_title>Neurological Outcomes With in THAI National HAART Program.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rajavithi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rajavithi Biomolecular Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rajavithi Hospital</source>
  <brief_summary>
    <textblock>
      After Initiation of HAART in peoples who living with HIV/AIDS in Thailand by the year 2000,
      rapidly expanded HAART access of national project has been promoted in 2004. Free ARVs (For
      CD4&lt;200cell/cu.mm. or in symptomatic HIV with CD4&lt;250 cell/cu.mm. )and CD4 monitoring has
      been available. The first-line regimen is d4T+3TC+NVP in mainly the first time (Naive)
      patients. CD4 response ), rate of opportunistic infection, and neurological outcomes were
      measured. Rate of ARV change, adverse events,treatment failure, TB co-infection rate, percent
      changing to EFV-based regimen or PI-based regimen were recorded.

      Any Adverse Events including, Sever rash, Severe Hepatitis, Lipid abnormalities, Severe
      Anemia and Other, common AEs will be analysed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date>September 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population, Natural History</observational_model>
    <time_perspective>Cross-Sectional, Retrospective/Prospective</time_perspective>
  </study_design_info>
  <enrollment>500</enrollment>
  <condition>HIV</condition>
  <condition>AIDS</condition>
  <condition>Neurological Complications</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Highly Active Antiretroviral Treatment (combination of :NRTI, NNRTI,or PI)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV/AIDS patients.

          -  Age &gt;15 years.

          -  informed consent

        Exclusion Criteria:

          -  Not informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Subsai Kongsaengdao, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rajavithi Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rajavithi Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lumpang Hospital</name>
      <address>
        <city>Lumpang</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sappasithiprasong Hospital</name>
      <address>
        <city>Ubonratchathani</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>August 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2006</study_first_submitted>
  <study_first_submitted_qc>August 22, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2006</study_first_posted>
  <last_update_submitted>August 22, 2006</last_update_submitted>
  <last_update_submitted_qc>August 22, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 23, 2006</last_update_posted>
  <keyword>HIV</keyword>
  <keyword>AIDS</keyword>
  <keyword>Neurological complications</keyword>
  <keyword>HAART</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

